Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Change in Management
Pursuant to the provisions of Regulation 30 of Listing Regulations, we hereby inform that the members of the Company at the 70th Annual General Meeting held today ('AGM'), have approved the following: (i) Appointment of Directors (ii) Appointment of new Statutory Auditors (iii) Dividend Fermenta Biotech Ltd - 506414 - Declaration Of Voting Results Of The 70Th Annual General Meeting
Pursuant to Regulation 44 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the results of remote e-voting (including ballot forms and electronic voting at the Annual General Meeting) on all the resolutions set out in the notice of the 70th Annual General Meeting of the Company held on August 12, 2022 through Video Conferencing/Other Audio Visual Means. Kindly take the same on record. Fermenta Biotech Ltd - 506414 - Declaration Of Voting Results Of The 70Th Annual General Meeting
Pursuant to Regulation 44 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the results of remote e-voting (including ballot forms and electronic voting at the Annual General Meeting) on all the resolutions set out in the notice of the 70th Annual General Meeting of the Company held on August 12, 2022 through Video Conferencing/Other Audio Visual Means. Kindly take the same on record. Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
We write to inform you that the Board of Directors of the Company at its meeting held on August 12, 2022 has, inter alia, approved the unaudited financial results for the quarter ended June 30, 2022 (Standalone and Consolidated) as enclosed. We are enclosing herewith the Limited Review Report dated August 12, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. Kindly take the above on record. The Board meeting commenced at 11.15 a.m. and concluded at 11.50 a.m. Fermenta Biotech Ltd - 506414 - Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
We write to inform you that the Board of Directors of the Company at its meeting held on August 12, 2022 has, inter alia, approved the unaudited financial results for the quarter ended June 30, 2022 (Standalone and Consolidated) as enclosed. We are enclosing herewith the Limited Review Report dated August 12, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. Kindly take the above on record. The Board meeting commenced at 11.15 a.m. and concluded at 11.50 a.m. Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, August 12, 2022, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter ended June 30, 2022. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019, the 'Trading Window" (period for trading in Company's securities) has been closed with effect from July 1, 2022 and shall continue to remain closed till 48 hours after declaration of unaudited financial results for the quarter ended June 30, 2022. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Fermenta Biotech Limited - Publication of Notice to equity shareholders Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith photocopy of the newspaper publication published in Business Standard, Mumbai (English version) on page no. 16 and Sakal, Mumbai (Marathi version) on page no. 9 dated August 2, 2022 for your reference and record. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of 'Notice of the Meetings of Equity Shareholders and Secured and Unsecured Creditors of Fermenta Biotech Limited' Fermenta Biotech Ltd - 506414 - Notice Of NCLT Convened Meeting Of Secured Creditors Of Fermenta Biotech Limited
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform that the Notice of NCLT convened Meeting of Secured Creditors of Fermenta Biotech Limited dated July 30, 2022 was sent by way of hand delivery and e-mail (to those creditors whose email addresses are duly registered with the Company) on August 1, 2022 for seeking approval for the Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited ('FBL' or 'Transferee Company') and their respective Shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The above Notice to Secured Creditors of the Company was sent pursuant to the directions of the Hon''ble National Company Law Tribunal, Bench at Mumbai in order dated July 19, 2022. Fermenta Biotech Ltd - 506414 - Notice Of NCLT Convened Meeting Of Unsecured Creditors Of Fermenta Biotech Limited
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform that the Notice of NCLT convened Meeting of Unsecured Creditors of Fermenta Biotech Limited dated July 30, 2022 was sent by way of courier and e-mail (to those creditors whose email addresses are duly registered with the Company) on August 1, 2022 for seeking approval for the Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited ('FBL' or 'Transferee Company') and their respective Shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The above Notice to Unsecured Creditors of the Company was sent pursuant to the directions of the Hon''ble National Company Law Tribunal, Bench at Mumbai in order dated July 19, 2022.